open access

Vol 26, No 3 (2019)
Original articles — Clinical cardiology
Published online: 2017-07-14
Get Citation

Simple platelet markers: Mean platelet volume and congestive heart failure coexistent with periodontal disease. Pilot studies

Maciej R. Czerniuk, Zbigniew Bartoszewicz, Iwona Dudzik-Niewiadomska, Tomasz Pilecki, Renata Górska, Krzysztof J. Filipiak
DOI: 10.5603/CJ.a2017.0085
·
Pubmed: 28714524
·
Cardiol J 2019;26(3):253-259.

open access

Vol 26, No 3 (2019)
Original articles — Clinical cardiology
Published online: 2017-07-14

Abstract

Background: Conducted pilot study concerning mean platelet volume (MPV) parameter among patients suffering from congestive heart failure and periodontal disease.

Methods: Examination of dynamic changes of platelet and periodontal markers in group of 50 patients before and an average of 6 months subsequent to professional periodontal treatment.

Results: Both platelet and periodontal parameters decreased after periodontal treatment, what is more, the decrease of MPV value due to periodontal disease/mm improvement was shown to be statistically significant (p = 0.05).

Conclusions: Improvement of periodontal status may influence decrease of MPV value and increase of congestive heart failure treatment efficacy and effect patient comfort. It is a new, not frequently used pattern of chronic disease treatment optimalization.

Abstract

Background: Conducted pilot study concerning mean platelet volume (MPV) parameter among patients suffering from congestive heart failure and periodontal disease.

Methods: Examination of dynamic changes of platelet and periodontal markers in group of 50 patients before and an average of 6 months subsequent to professional periodontal treatment.

Results: Both platelet and periodontal parameters decreased after periodontal treatment, what is more, the decrease of MPV value due to periodontal disease/mm improvement was shown to be statistically significant (p = 0.05).

Conclusions: Improvement of periodontal status may influence decrease of MPV value and increase of congestive heart failure treatment efficacy and effect patient comfort. It is a new, not frequently used pattern of chronic disease treatment optimalization.

Get Citation

Keywords

mean platelet volume; platelets; congestive heart failure; periodontal disease; inflammatory response

About this article
Title

Simple platelet markers: Mean platelet volume and congestive heart failure coexistent with periodontal disease. Pilot studies

Journal

Cardiology Journal

Issue

Vol 26, No 3 (2019)

Pages

253-259

Published online

2017-07-14

DOI

10.5603/CJ.a2017.0085

Pubmed

28714524

Bibliographic record

Cardiol J 2019;26(3):253-259.

Keywords

mean platelet volume
platelets
congestive heart failure
periodontal disease
inflammatory response

Authors

Maciej R. Czerniuk
Zbigniew Bartoszewicz
Iwona Dudzik-Niewiadomska
Tomasz Pilecki
Renata Górska
Krzysztof J. Filipiak

References (35)
  1. Karataş MB, Çanga Y, İpek G, et al. Association of admission serum laboratory parameters with new-onset atrial fibrillation after a primary percutaneous coronary intervention. Coron Artery Dis. 2016; 27(2): 128–134.
  2. Bolat I, Akgul O, Cakmak HA, et al. The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kardiol Pol. 2016; 74(4): 346–355.
  3. Sansanayudh N, Numthavaj P, Muntham D, et al. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost. 2015; 114(6): 1299–1309.
  4. Yılmaz F, Köklü E, Kizilirmak Yilmaz F, et al. Evaluation of mean platelet volume and platelet distribution width in patients with asymptomatic intermediate carotid artery plaque. Kardiol Pol. 2017; 75(1): 35–41.
  5. İleri M, Kanat S, Gürsoy HT, et al. Increased mean platelet volume in rheumatic mitral stenosis: assessment of clinical and echocardiographic determinants. Kardiol Pol. 2015; 73(1): 46–53.
  6. Łysek R, Szafraniec K, Polak M, et al. Relationship between past myocardial infarction, periodontal disease and Porphyromonas gingivalis serum antibodies: A case-control study. Cardiol J. 2018; 25(3): 386–392.
  7. Wożakowska-Kapłon B, Włosowicz M, Gorczyca-Michta I, et al. Oral health status and the occurrence and clinical course of myocardial infarction in hospital phase: a case-control study. Cardiol J. 2013; 20(4): 370–377.
  8. Androsz-Kowalska O, Jankowski K, Rymarczyk Z, et al. Correlation between clinical parameters of periodontal disease and mean platelet volume in patients with coronary artery disease: a pilot study. Kardiol Pol. 2013; 71(6): 600–605.
  9. Kandis H, Ozhan H, Ordu S, et al. The prognostic value of mean platelet volume in decompensated heart failure. Emerg Med J. 2011; 28(7): 575–578.
  10. Budak YU, Huysal K, Demirci H. Correlation between mean platelet volume and B-type natriuretic peptide concentration in emergency patients with heart failure. Biochem Med (Zagreb). 2015; 25(1): 97–102.
  11. Czerniuk M, Filipiak KJ, Górska R, et al. [Periodontal state and cardiovascular diseases]. Pol Arch Med Wewn. 1999; 101(5): 433–436.
  12. Czerniuk MR, Górska R, Filipiak KJ, et al. Inflammatory response to acute coronary syndrome in patients with coexistent periodontal disease. J Periodontol. 2004; 75(7): 1020–1026.
  13. Czerniuk MR, Górska R, Filipiak KJ, et al. C-reactive protein in patients with coexistent periodontal disease and acute coronary syndromes. J Clin Periodontol. 2006; 33(6): 415–420.
  14. Zaremba M, Górska R, Suwalski P, et al. Periodontitis as a risk factor of coronary heart diseases? Adv Med Sci. 2006; 51 Suppl 1: 34–39.
  15. Czerniuk MR, Gorska R, Filipiak KJ, et al. The influence of periodontal diseases on intensivity and dynamice of inflammation response in patients with acute coronary syndromes. Dent Med Probl. 2002; 39(1): 31–37.
  16. Czerniuk MR, Eickholz P, Grötz KA. Oral cavity infections: why should cardiologists care about them? Kardiol Pol. 2015; 73(10): 901–908.
  17. Czerniuk M, Bartoszewicz Z, Filipiak K, et al. Osoczowe stężenia NT-proBNP u pacjentów z niewydolnością serca i współistniejącą chorobą przyzębia: badania pilotażowe. Kardiol Pol. 2017; 75(2): 135–142.
  18. Saffi MA, Furtado MV, Polanczyk CA, et al. Relationship between vascular endothelium and periodontal disease in atherosclerotic lesions: Review article. World J Cardiol. 2015; 7(1): 26–30.
  19. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107(3): 499–511.
  20. D'Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004; 83(2): 156–160.
  21. Higashi Y, Noma K, Yoshizumi M, et al. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009; 73(3): 411–418.
  22. de Araújo Júnior RF, Souza TO, de Medeiros CA, et al. Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. PLoS One. 2013; 8(7): e66391.
  23. Lange DE, Plagman HC, Eenboom A, et al. Klinische Bewertungsverfaren zur Obiekitiverung der Mundhygiene. Dtsch Zahnarztl Z. 1977; 32: 44–47.
  24. Hall WB. Critical Decisions in Periodontology. Fourth Edition, BC Decker Inc, Hamilton, London 2003: 30–31.
  25. Hall WB. Clinical Practice. In: Steele PF (ed). Dimensions of Dental Hygiene. Third Edition. Lea&Febiger, Philiadelphia 1982: 153.
  26. Dibart S, Dietrich T. Practical periodontal diagnostic and treatment planning. Chapter 2. Wiley-Blackwell, Iowa 2010.
  27. Kaisare S, Rao J, Dubashi N. Periodontal disease as a risk factor for acute myocardial infarction. A case-control study in Goans highlighting a review of the literature. Br Dent J. 2007; 203(3): 144–145.
  28. Ximénez-Fyvie LA, Haffajee AD, Socransky SS. Comparison of the microbiota of supra- and subgingival plaque in health and periodontitis. J Clin Periodontol. 2000; 27(9): 648–657.
  29. Dorn JM, Genco RJ, Grossi SG, et al. Periodontal disease and recurrent cardiovascular events in survivors of myocardial infarction (MI): the Western New York Acute MI Study. J Periodontol. 2010; 81(4): 502–511.
  30. Blair FM, Chapple ILC. Prescribing for periodontal disease. Prim Dent J. 2014; 3(4): 38–43.
  31. Chukkapalli SS, Velsko IM, Rivera-Kweh MF, et al. Polymicrobial oral infection with four periodontal bacteria orchestrates a distinct inflammatory response and atherosclerosis in apoe null mice. PLoS One. 2015; 10(11): e0143291.
  32. Beck JD, Eke P, Heiss G, et al. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation. 2005; 112(1): 19–24.
  33. Tonetti MS, Eickholz P, Loos BG, et al. Principles in prevention of periodontal diseases: Consensus report of group 1 of the 11(th) European Workshop on Periodontology on effective prevention of periodontal and peri-implant diseases. J Clin Periodontol. 2015; 42(Suppl 16): 5–11.
  34. Seymour RA. Is gum disease killing your patient? Br Dent J. 2009; 206(10): 551–552.
  35. Meyer-Bäumer A, Eick S, Mertens C, et al. Periodontal pathogens and associated factors in aggressive periodontitis: results 5-17 years after active periodontal therapy. J Clin Periodontol. 2014; 41(7): 662–672.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl